海洋真菌来源丁内酯I的单胺氧化酶抑制活性及结构类似物虚拟筛选Monoamine Oxidase Inhibition of Butyrolactone I from Marine Aspergillus terreus and Virtual Screening of Its Analogs
杨煜,周龙建,刘亚月,王远,张翼
摘要(Abstract):
【目的】为研究海洋土曲霉(Aspergillus terreus)C23-3的次级代谢产物中的单胺氧化酶抑制剂及其抑制作用类型,借助计算机模拟方法探讨同类型化合物对单胺氧化酶的潜在抑制活性及构效关系,以开发单胺氧化酶抑制剂。【方法】采用活性引导下的色谱方法分离纯化得到活性化合物,采用核磁共振、质谱、圆二色谱分析鉴定其结构,采用酶标比色法评价化合物对单胺氧化酶抑制作用。使用Autodock vina对其结构类似物进行抑制单胺氧化酶活性虚拟筛选。【结果】1)分离鉴定得到一个具有单胺氧化酶抑制活性的化合物丁内酯I;2)丁内酯I对单胺氧化酶A和单胺氧化酶B的抑制作用为可逆非竞争性抑制,对单胺氧化酶A的半抑制浓度(IC_(50))为21.45μmol/L,抑制常数K_i=6.27μmol/L;对单胺氧化酶B的IC_(50)为24.16μmol/L,K_i=12.61μmol/L;3)分子对接显示丁内酯I可与单胺氧化酶形成多个氢键,五元内酯环为α,γ?二芳基取代、含有苯并吡喃或苯并呋喃基团的aspvinone类丁内酯化合物在虚拟筛选中对单胺氧化酶最小结合亲和力得分更低(即结合力更强)。【结论】丁内酯I是可逆的单胺氧化酶抑制剂,对单胺氧化酶的抑制为非竞争性抑制。真菌来源丁内酯类化合物可作为单胺氧化酶抑制剂的新来源。
关键词(KeyWords): 海洋真菌;次级代谢产物;单胺氧化酶;抑制类型;虚拟筛选
基金项目(Foundation): 广东省基础与应用基础研究基金自然科学基金(面上项目)(2022A1515010783);; 广东省科技专项资金-基础与应用基础研究专题(2021A05240);; 国家自然科学基金(21807015);; 广东省普通高校重点领域专项(生物医药与健康)(2021ZDZX2064);; 深圳市科创委基础研究面上项目(JCYJ20220530162014032,JCYJ20190813105005619);; 湛江市海洋青年人才创新项目(2022E05010)
作者(Author): 杨煜,周龙建,刘亚月,王远,张翼
参考文献(References):
- [1]金黎明,金鑫浩,侯熙彦,等.具有抗菌活性的海洋真菌天然产物研究进展[J].中国海洋药物, 2017, 36(4):66-74.
- [2] TRIPATHI A C, UPADHYAY S, PALIWAL S, et al. Privileged scaffolds as MAO inhibitors:retrospect and prospects[J].European Journal of Medicinal Chemistry, 2018, 145:445-497.
- [3] JONES D N, RAGHANTI M A. The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders[J]. Journal of Chemical Neuroanatomy, 2021, 114:101957.
- [4] SAURA J, NADAL E, VAN DEN BERG B, et al. Localization of monoamine oxidases in human peripheral tissues[J]. Life Sciences, 1996, 59(16):1341-1349.
- [5] UEHARA S, UNO Y, YAMAZAKI H. Molecular cloning,sequence analysis, and tissue distribution of marmoset monoamine oxidases A and B[J]. Drug Metabolism and Pharmacokinetics, 2020, 35(5):479-482.
- [6] YANG J M, LIU Y Y, YANG W C, et al. An anti-inflammatory isoflavone from soybean inoculated with a marine fungus Aspergillus terreus C23-3[J]. Bioscience, Biotechnology,and Biochemistry, 2020, 84(8):1546-1553.
- [7]杨文聪,刘亚月,杨静明,等.盐酸普鲁卡因诱导下海洋真菌Hypocrea lixii次级代谢化学成分[J].广东海洋大学学报, 2020, 40(1):55-63.
- [8] LIANG J B, YANG Z D, SHU Z M, et al. A rapid thin-layer chromatography bioautographic method for detecting the monoamine oxidase inhibitors in plants[J]. Natural Product Research, 2014, 28(17):1318-1321.
- [9] HOLT A, SHARMAN D F, BAKER G B, et al. A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates[J]. Analytical Biochemistry,1997, 244(2):384-392.
- [10] BEKIRCAN O, DAN???,?AHIN M E, et al. Monoamine oxidase A and B inhibitory activities of 3, 5-diphenyl-1, 2,4-triazole substituted[1, 2, 4]triazolo[3, 4-b][1, 3, 4]thiadiazole derivatives[J]. Bioorganic Chemistry, 2022, 118:105493.
- [11] ZARMOUH N O, MESSEHA S S, ELSHAMI F M, et al.Evaluation of the isoflavone genistein as reversible human monoamine oxidase-A and-B inhibitor[J]. Evidence-Based Complementary and Alternative Medicine, 2016, 2016:1423052.
- [12] LEE H W, RYU H W, KANG M G, et al. Potent inhibition of monoamine oxidase A by decursin from Angelica gigas nakai and by wogonin from Scutellaria baicalensis Georgi[J]. International Journal of Biological Macromolecules,2017, 97:598-605.
- [13] YANG W C, ZHANG Y Y, LI Y J, et al. Chemical composition and anti-Alzheimer’s disease-related activities of a functional oil from the edible seaweed Hizikia fusiforme[J].Chemistry&Biodiversity, 2020, 17(8):e2000055.
- [14] BHAWNA, KUMAR A, BHATIA M, et al. Monoamine oxidase inhibitors:A concise review with special emphasis on structure activity relationship studies[J]. European Journal of Medicinal Chemistry, 2022, 242:114655.
- [15]刘冰,唐祉娟,陈宁,等.海洋来源曲霉丁内酯类次级代谢产物研究进展[J].中国海洋药物, 2021, 40(5):59-70.
- [16] IBRAHIM S R M, MOHAMED G A, KHEDR A I M.γ-butyrolactones from Aspergillus species:structures,biosynthesis, and biological activities[J]. Natural Product Communications, 2017, 12(5):791-800.
- [17]聂影影.抗阿尔茨海默症相关活性海藻和海洋真菌的筛选及其次级代谢产物的研究[D].湛江:广东海洋大学,2017.
- [18] MA X H, ZHU T J, GU Q Q, et al. Structures and antiviral activities of butyrolactone derivatives isolated from Aspergillus terreus MXH-23[J]. Journal of Ocean University of China, 2014, 13(6):1067-1070.
- [19] ZHOU M, DU G, YANG H Y, et al. Antiviral butyrolactones from the endophytic fungus Aspergillus versicolor[J]. Planta Medica, 2015, 81(3):235-240.
- [20] JALAL K, KHAN K, HALEEM D J, et al. In silico study to identify new monoamine oxidase type a(MAO-A)selective inhibitors from natural source by virtual screening and molecular dynamics simulation[J]. Journal of Molecular Structure, 2022, 1254:132244.
- [21] EL AISSOUQ A, BOUACHRINE M, OUAMMOU A, et al.Homology modeling, virtual screening, molecular docking,molecular dynamic(MD)simulation, and ADMET approaches for identification of natural anti-Parkinson agents targeting MAO-B protein[J]. Neuroscience Letters, 2022,786:136803.
- [22] LEWELLYN K, BIALONSKA D, CHAURASIYA N D,et al. Synthesis and evaluation of aplysinopsin analogs as inhibitors of human monoamine oxidase A and B[J].Bioorganic and Medicinal Chemistry Letters, 2012, 22(15):4926-4929.
- [23] DAS T, SAHA S C, SUNITA K, et al. Promising botanicalderived monoamine oxidase(MAO)inhibitors:pharmacological aspects and structure-activity studies[J]. South African Journal of Botany, 2022, 146:127-145.